Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Sales | 22,065 | 21,649 | 17,359 | 16,578 | 13,514 |
| Cost of Goods | 8,654 | 6,437 | 6,253 | 5,712 | 4,954 |
| Gross Profit | 13,411 | 15,212 | 11,106 | 10,866 | 8,560 |
| Operating Expenses | 4,129 | 6,548 | 2,709 | 3,147 | 3,274 |
| Operating Income | 9,936 | 9,101 | 8,650 | 8,431 | 6,240 |
| Other Income | 2,445 | 2,835 | 730 | 875 | 820 |
| Pre-tax Income | 12,381 | 11,936 | 9,380 | 9,306 | 7,060 |
| Income Tax | 4,589 | 4,449 | 3,554 | 3,444 | 2,642 |
| Net Income Continuous | 7,792 | 7,487 | 5,826 | 5,862 | 4,418 |
| Net Income | $7,792 | $7,487 | $5,826 | $5,862 | $4,418 |
| EPS Basic Total Ops | 0.24 | 0.23 | 0.20 | 0.20 | 0.15 |
| EPS Basic Continuous Ops | 0.24 | 0.23 | 0.20 | 0.20 | 0.15 |
| EPS Diluted Total Ops | 0.23 | 0.22 | 0.19 | 0.19 | 0.14 |
| EPS Diluted Continuous Ops | 0.23 | 0.22 | 0.19 | 0.19 | 0.14 |
| EBITDA(a) | $11,051 | $9,789 | $9,254 | $8,987 | $6,805 |